Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Equity: 2020-2023

Historic Return on Equity for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to 4.89%.

  • ADC Therapeutics' Return on Equity rose 614.00% to 4.89% in Q3 2023 from the same period last year, while for Sep 2023 it was 4.89%, marking a year-over-year increase of 614.00%. This contributed to the annual value of -0.00% for FY2022, which is N/A change from last year.
  • As of Q3 2023, ADC Therapeutics' Return on Equity stood at 4.89%, which was up 144.41% from -11.01% recorded in Q2 2023.
  • ADC Therapeutics' 5-year Return on Equity high stood at 4.89% for Q3 2023, and its period low was -11.01% during Q2 2023.
  • For the 3-year period, ADC Therapeutics' Return on Equity averaged around -1.85%, with its median value being -1.29% (2021).
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Return on Equity showed a top increase of 614bps in 2023 and a maximum decrease of 988bps in 2023.
  • ADC Therapeutics' Return on Equity (Quarterly) stood at -4.94% in 2020, then spiked by 394bps to -2.08% in 2021, then skyrocketed by 59bps to -1.49% in 2022, then skyrocketed by 614bps to 4.89% in 2023.
  • Its last three reported values are 4.89% in Q3 2023, -11.01% for Q2 2023, and -3.04% during Q1 2023.